{"version":"1.0","provider_name":"IRLAB","provider_url":"https:\/\/irlab.se\/sv\/","title":"Nyemission 2026 - IRLAB","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qXfDXB9i6y\"><a href=\"https:\/\/irlab.se\/sv\/investerare\/nyemission-2026\/\">Nyemission 2026<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/irlab.se\/sv\/investerare\/nyemission-2026\/embed\/#?secret=qXfDXB9i6y\" width=\"600\" height=\"338\" title=\"\u201dNyemission 2026\u201d &ndash; IRLAB\" data-secret=\"qXfDXB9i6y\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/irlab.se\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"IRLAB:s pipeline kan revolutionera behandlingen av Parkinson Det svenska biofarmabolaget IRLAB har fem l\u00e4kemedelskandidater med potential att behandla de symtom som har st\u00f6rst p\u00e5verkan p\u00e5 livskvaliteten vid Parkinsons sjukdom. Med sin breda pipeline och tre l\u00e4kemedelskandidater i klinisk fas har bolaget en unik position inom neurodegenerativa sjukdomar. Bolaget genomf\u00f6r nu en kapitalanskaffning f\u00f6r att skapa [&hellip;]"}